Peritonitis Dr. Efman

Embed Size (px)

Citation preview

  • 7/28/2019 Peritonitis Dr. Efman

    1/41

    PERITONITIS

    Professor Dr. Wael ElShaer

  • 7/28/2019 Peritonitis Dr. Efman

    2/41

    Anatomy

    The peritoneum is the largest and most complex serousmembrane in the body.

    It forms a closed sac (ie, coelom) by lining the interiorsurfaces of the abdominal wall (anterior and lateral), by

    forming the boundary to the retroperitoneum(posterior), by covering the extraperitoneal structuresin the pelvis (inferior), and by covering theundersurface of the diaphragm (superior).

    This parietal layer of the peritoneum reflects onto theabdominal visceral organs to form the visceralperitoneum. It thereby creates a potential spacebetween the 2 layers (ie, the peritoneal cavity).

  • 7/28/2019 Peritonitis Dr. Efman

    3/41

    Normally, the amount of peritoneal fluid present is lessthan 50 mL, and only small volumes are transferred acrossthe considerable surface area in a steady state each day.

    The peritoneal fluid represents a plasma ultrafiltrate, with

    electrolyte and solute concentrations similar to that ofneighboring interstitial spaces and a protein content of lessthan 30 g/L, mainly albumin.

    In addition, peritoneal fluid contains small numbers ofdesquamated mesothelial cells.

    Intraperitoneal fluid travels continuously in an upwarddirection to the subphrenic regions.

    Large amounts of fluid runs downwards.

  • 7/28/2019 Peritonitis Dr. Efman

    4/41

    Innervations:

    The parietal peritoneum is sensitive and isinnervated by both somatic and visceral

    afferent nerves. Any local insult leads tovoluntary muscle guarding and spasm,localized severe pain.

    The visceral peritoneum received only fromautonomic nervous system and is relativelyinsensitive, with vague poorly localized pain.

  • 7/28/2019 Peritonitis Dr. Efman

    5/41

    Definition

    Peritonitis is defined as inflammation of theserosal membrane that lines the abdominalcavity and the organs contained there in.

    Peritoneal infections are classified as: Primary (i.e., spontaneous)

    Secondary (i.e., related to a pathologic process ina visceral organ)

    Tertiary (i.e., persistent or recurrent infection afteradequate initial therapy.)

  • 7/28/2019 Peritonitis Dr. Efman

    6/41

    Primary bacterial peritonitis refers to spontaneous bacterialinvasion of the peritoneal cavity. This mainly occurs in infancy andearly childhood, in cirrhotic patients and immunocompromisedhosts.

    Secondary bacterial peritonitis describes peritoneal infections

    secondary to intraabdominal lesions, such as perforation of thehollow viscus, bowel necrosis, nonbacterial peritonitis, orpenetrating infectious processes.

    Tertiary peritonitis, a less well-defined entity, is characterized bypersistent or recurrent infections with organisms of low intrinsicvirulence or with predisposition for the immunocompromised

    patient. It usually follows operative attempts to treat secondaryperitonitis and is almost exclusively associated with a systemicinflammatory response.

  • 7/28/2019 Peritonitis Dr. Efman

    7/41

    Clinically peritonitis is often classified either as

    local or as diffuse.

    Local peritonitis refers to loculi of infection,

    usually walled-off or contained by adjacent

    organs,

    Diffuse is synonymous with generalized

    peritonitis, that is spread to the entire cavity.

  • 7/28/2019 Peritonitis Dr. Efman

    8/41

    Peritonitis

    The most common etiology of primaryperitonitis is spontaneous bacterial peritonitisdue to chronic liver disease

    The common etiologic entities of secondaryperitonitis include:

    Perforated gastric and duodenal ulcer disease

    Perforated (sigmoid) colon caused by diverticulitis,volvulus, or cancer

    Strangulation of the small bowel

  • 7/28/2019 Peritonitis Dr. Efman

    9/41

    Secondary Peritonitis

    Causative organisms: Pyogenic bacteria, E.coli, aerobic and anaerobic,

    Streptococci, Bacteroides, Pneumococci,Staphylococci

    Sources of infection: Local spread:

    infected organs: appendicitis, cholecystitis, diverticulitis.

    Leaking organs:

    perforated peptic ulcer, perforated typhoid ulcer, leakinganastomosis, ruptured gut, extravasated urine

    Direct entry (operative or traumatic)

    Blood spread (bacteremia, septicemia)

  • 7/28/2019 Peritonitis Dr. Efman

    10/41

    Common Causes of Secondary Peritonitis

    Source Regions Causes

    Esophagus Borhaave syndromeMalignancy

    Trauma (mostly penetrating)

    latrogenic

    Stomach Peptic Ulcer Perforation

    Malignancy (e.g., adenocarcinoma, lymphoma, gastrointestinalstromal tumor)

    Trauma (mostly penetrating)

    latrogenic

    Duodenum Peptic Ulcer perforationTrauma (blunt and penetrating)

    latrogenic

    Biliary tract CholecystitusStone perforation from gallbladder (i.e., gallstones ileus) or

    common duct

    Malignancy

    Choledochal cyst (rare)

    Trauma (mostly penetrating)Latrogenic

  • 7/28/2019 Peritonitis Dr. Efman

    11/41

    Common Causes of Secondary PeritonitisSource Regions Causes

    Pancreas PancreatitisTrauma (blunt and penetrating)

    latrogenic

    Small bowel Ischemic bowelIncarcerated hernia (internal and external)

    Closed loop obstruction, Crohn disease

    Malignancy (rare)

    Meckel diverticulum

    Trauma (mostly penetrating)

    Large bowel andappendix

    Ischemic bowel

    Diverticulitus, Malignancy

    Ulcerative colitis and Crohn disease

    Appendicitus, Colonic volvulus

    Trauma (mostly penetrating )

    latrogenic

    Uterus, salpinx,

    and ovaries

    Pelvic inflammatory disease (e.g., salpingoophoritis,

    tuboovarian abscess, ovarian cyst)

    Malignancy (rare)

    Trauma (uncommon)

  • 7/28/2019 Peritonitis Dr. Efman

    12/41

    Causes

    Iatrogenic trauma to the upper GI tract, including thepancreas and biliary tract and colon, often results fromendoscopic procedures; anastomotic dehiscence andinadvertent bowel injury (eg, mechanical, thermal) arecommon causes of leak in the postoperative period.

    After elective abdominal operations for noninfectiousetiologies, the incidence of SP (caused by anastomoticdisruption, breakdown of enterotomy closures, orinadvertent bowel injury) should be less than 2%.

    Operations for inflammatory disease (ie, appendicitis,diverticulitis, cholecystitis) without perforation carry a riskofless than 10% for the development of SP and peritonealabscess. This risk may rise to greater than 50% ingangrenous bowel disease and visceral perforation.

  • 7/28/2019 Peritonitis Dr. Efman

    13/41

    Spontaneous bacterial peritonitis

    The most common etiology of primary peritonitis isspontaneous bacterial peritonitis (SBP) due to chronic liverdisease. Approximately 10-30% of all patients with livercirrhosis who have ascites develop bacterial peritonitis overtime.

    SBP occurs in the absence of an apparent intra-abdominalsource of infection and is observed almost exclusively inpatients with ascites formation from chronic liver disease.Contamination of the peritoneal cavity is thought to resultfrom translocation of bacteria across the gut wall or

    mesenteric lymphatics and, less frequently, viahematogenous seeding in the presence of bacteremia.

    More than 90% of cases of SBP are caused by amonomicrobial infection.

  • 7/28/2019 Peritonitis Dr. Efman

    14/41

    Tertiary peritonitis

    Tertiary peritonitis represents the persistence or recurrence of peritonealinfection following apparently adequate therapy of SBP or SP, often without theoriginal visceral organ pathology.

    Patients with tertiary peritonitis usually present with an abscess, or phlegmon,with or without fistulization.

    Tertiary peritonitis develops more frequently in patients with significant

    preexisting comorbid conditions and in patients who are immunocompromised.Although rarely observed in uncomplicated peritoneal infections, the incidence oftertiary peritonitis in patients requiring ICU admission for severe abdominalinfections may be as high as 50-74%.

    Patients who develop tertiary peritonitis demonstrate significantly longer lengthsof stay in the ICU and hospital, higher organ dysfunction scores, and highermortality rates (50-70%). Resistant and unusual organisms (eg, Enterococcus,

    Candida, Staphylococcus, Enterobacter, and Pseudomonas species) are found in asignificant proportion of cases of tertiary peritonitis.

    Most patients with tertiary peritonitis develop complex abscesses or poorlylocalized peritoneal infections that are not amenable to percutaneous drainage.Antibiotic therapy appears less effective compared to all other forms of peritonitis.

  • 7/28/2019 Peritonitis Dr. Efman

    15/41

    Tuberculous peritonitis (TP)

    The presenting symptoms are often nonspecific and insidious in onset (eg,lowgrade fever, anorexia, weight loss).

    More than 95% of patients have evidence of ascites on imaging studies, and morethan half of these patients have clinically apparent ascites.

    Most patients have evidence of cirrhosis, and the diagnosis of TP may beunsuspected.

    Chest radiograph findings are abnormal in most patients, but active pulmonarydisease is present in fewer than 30% of patients.

    Results on Gram stain of ascitic fluid are rarely positive, and culture results may befalsely negative in up to 80% of patients. A peritoneal fluid protein level greaterthan 2.5 g/dL, lactate dehydrogenase (LDH) level greater than 90 U/mL, orpredominantly mononuclear cell count greater than 500 cells/l should raisesuspicion but has limited specificity for the diagnosis.

    Laparoscopy and visualization of granulomas on peritoneal biopsy specimens, aswell as positive results on cultures (requires 4-6 wk) may be needed for thedefinitive diagnosis; however, empiric therapy should begin immediately.

  • 7/28/2019 Peritonitis Dr. Efman

    16/41

    Chemical (sterile) peritonitis

    Chemical (sterile) peritonitis may be caused byirritant substances such as bile, blood, barium,and other substances or by transmural

    inflammatory processes of visceral organs (eg,Crohns disease) without bacterial inoculation ofthe peritoneal cavity.

    Clinical signs and symptoms are indistinguishable

    from those of SP or peritoneal abscess, and thediagnostic and therapeutic approach should bethe same.

  • 7/28/2019 Peritonitis Dr. Efman

    17/41

    Pathophysiology

    Peritonitis causes a reduction in the intra-abdominal fibrinolyticactivity (increased plasminogen activator inhibitor activity) andfibrin sequestration with subsequent adhesion formation.

    The production of fibrinous exudates is considered an important

    part of the host defense, but large numbers of bacteria may besequestered within the fibrin matrix.

    This may lead to retardation of spread and systemic disseminationand may decrease early mortality rates from sepsis, but it also isintegral to the development of residual infection and abscessformation. As the fibrin matrix matures, the bacteria within are

    protected from host clearance mechanisms.

  • 7/28/2019 Peritonitis Dr. Efman

    18/41

    Signs and Symptoms

    Abdominal pain. This pain may be acute or more insidious in onset. Initially, the pain is

    often dull and poorly localized (visceral peritoneum) and thenprogresses to steady, severe, and more localized pain (parietalperitoneum). If the infectious process is not contained, the painbecomes diffuse.

    In certain disease entities (e.g., gastric perforation, severe acutepancreatitis, intestinal ischemia), the abdominal pain may begeneralized from the beginning.

    Anorexia and nausea are frequently present and may precede thedevelopment of abdominal pain. Vomiting may occur because ofthe underlying visceral organ pathology (i.e., obstruction) orsecondary to the peritoneal irritation.

    Abdominal distension

    Absolute constipation (diarrhoea and tenesmus if pelvic collection)

  • 7/28/2019 Peritonitis Dr. Efman

    19/41

    Physical Examination

    Fever with temperatures that can exceed 38C isusually present, but patients with severe sepsis maypresent with hypothermia.

    Tachycardia is caused by the release of inflammatory

    mediators and intravascular hypovolemia caused byanorexia and vomiting, fever, and third-space lossesinto the peritoneal cavity.

    With progressive dehydration, patients may becomehypotensive, they may demonstrate decreased urine

    output, and, with severe peritonitis. They may present in overt septic shock.

    Facies Hippocratica

  • 7/28/2019 Peritonitis Dr. Efman

    20/41

    Abdominal Examination

    Tenderness to palpation

    In most patients, the point of maximal tenderness or referredrebound tenderness roughly overlies the pathologic process.

    Nearly all patients demonstrate increased abdominal wall rigidity.The increase in abdominal wall muscular tone may be voluntary in

    response to or in anticipation of the abdominal examination orinvoluntary because of the peritoneal irritation.

    Patients with severe peritonitis often avoid all motion and keeptheir hips flexed to relieve the abdominal wall tension.

    The abdomen is often distended

    Hypoactive-to-absent bowel sounds. This finding reflects ageneralized ileus and may not be present if the infection is welllocalized.

    Occasionally, the abdominal examination reveals an inflammatorymass.

  • 7/28/2019 Peritonitis Dr. Efman

    21/41

    Rectal examination often elicits increased abdominalpain, particularly with inflammation of the pelvicorgans but rarely indicates a specific diagnosis.

    A tender inflammatory mass toward the right mayindicate appendicitis, and anterior fullness andfluctuation may indicate a cul de sac abscess.

    In female patients, vaginal and bimanual examinationmay lead to the differential diagnosis of pelvic

    inflammatory disease (e.g., endometritis, salpingo-oophoritis, tubo-ovarian abscess), but the findings areoften difficult to interpret in severe peritonitis.

  • 7/28/2019 Peritonitis Dr. Efman

    22/41

    Thoracic processes with diaphragmatic irritation(e.g., empyema),

    Extraperitoneal processes (e.g., pyelonephritis,

    cystitis, acute urinary retention), and Abdominal wall processes (e.g., infection, rectus

    hematoma) may mimic certain signs andsymptoms of peritonitis.

    Always examine the patient carefully for thepresence ofexternal hernias to rule out intestinalincarceration.

  • 7/28/2019 Peritonitis Dr. Efman

    23/41

    Laboratory Studies

    CBC with differential, serum electrolytes with renal function Most patients with intra-abdominal infections demonstrate leukocytosis (>11,000 cells/L)

    with a shift to the immature forms on the differential cell count. Patients in severe sepsis,patients who are immuno-compromised, and patients with certain types of infections (e.g.,fungal, cytomegaloviral) may demonstrate absence of leukocytosis or leucopenia.

    Blood chemistry may reveal dehydration and acidosis.

    PT, PTT, and INR

    Liver function tests if clinically indicated Amylase and lipase if pancreatitis is suspected

    Urinalysis (UA) is essential to rule out urinary tract diseases (e.g., pyelonephritis,renal stone disease); however, patients with lower abdominal and pelvic infectionsoften demonstrate WBCs in the urine and microhematuria.

    In patients with diarrhea, evaluate a stool sample for Clostridium difficile toxin

    assay, WBC count, and specific culture (i.e., Salmonella, Shigella, cytomegalovirus[CMV]) if the patient's history suggests infectious enterocolitis.

    Aerobic and anaerobic blood cultures

  • 7/28/2019 Peritonitis Dr. Efman

    24/41

    Peritoneal fluid

    When assessing a peritoneal fluid sample forperitoneal infection, evaluate the sample for pH,glucose, protein, lactate dehydrogenase (LDH), cellcount, Gram stain, and aerobic and anaerobic cultures.

    Obtain a peritoneal fluid amylase analysis ifpancreatitis or pancreatic leak is suspected.

    Obtain a fluid bilirubin analysis when a biliary leak issuspected

    Evaluate the fluid creatinine level when a urinary leakissuspected. Compare the peritoneal levels to therespective serum levels.

  • 7/28/2019 Peritonitis Dr. Efman

    25/41

    Tuberculosis Peritonitis

    The fluid Gram stain and acid-fast stain results arerarely positive, and routine culture findings arefalsely negative in as many as 80% of cases.

    A peritoneal fluid protein level greater than 2.5g/dL, LDH level greater than 90 U/mL, andpredominantly mononuclear cell count of morethan 500 cells/L should raise the suspicion of TP,but specificity for the diagnosis is limited.

    Laparoscopy with visualization of granulomas onperitoneal biopsy and specific culture (requires 4-6 wk) may be needed for definitive diagnosis.

  • 7/28/2019 Peritonitis Dr. Efman

    26/41

    Imaging Studies

    Radiographs Plain films of the abdomen (e.g., supine, upright, and

    lateral decubitus positions) are often the first imagingstudies obtained in patients presenting with peritonitis.Their value in reaching a specific diagnosis is limited.

    Free air is present in most cases of anterior gastric andduodenal perforation but is much less frequent withperforations of the small bowel and colon and is unusualwith appendiceal perforation. Upright films are useful foridentifying free air under the diaphragm (most often on

    the right) as an indication of a perforated viscous. A leftsidedown lateral decubitus film might help to make thediagnosis.

  • 7/28/2019 Peritonitis Dr. Efman

    27/41

    Ultrasound

    May be helpful in the evaluation ofright upper quadrant(perihepatic abscess, cholecystitis, pancreatitis, pancreaticpseudocyst), right lower quadrant, and pelvic pathology (e.g.,appendicitis, tubo-ovarian abscess,

    Douglas pouch abscess),

    Ultrasonography may detect increased amounts of peritoneal fluid(ascites), but its ability to detect quantities of less than 100 mL islimited.

    Ultrasound-guided aspiration and placement of drains has evolvedinto a valuable tool in the diagnosis and treatment of abdominalfluid collections

    But the examination is sometimes limited because of patientdiscomfort, abdominal distension, and bowel gas interference.

  • 7/28/2019 Peritonitis Dr. Efman

    28/41

    CT Scan

    The diagnostic study of choice for peritoneal abscessand the related visceral pathology. CT scan is indicated in all cases where the diagnosis cannot

    be established on clinical grounds and findings onabdominal plain films.

    Whenever possible, the CT scan should be performed withenteral and intravenous contrast.

    CT scans can detect small quantities of fluid, areas ofinflammation, and other GI tract pathology, withsensitivities that approach 100%.

    Peritoneal abscesses and other fluid collections may beaspirated for diagnosis and drained under CT guidance;this technique has become a mainstay of therapy.

  • 7/28/2019 Peritonitis Dr. Efman

    29/41

    Treatment

    The general principles guiding the treatment ofintra-abdominal infections are 4-fold:

    (1) to control the infectious source

    (2) to eliminate bacteria and toxins(3) to maintain organ system function

    (4) to control the inflammatory process.

    Medical, interventional, and operative treatmentoptions are complimentary, not competitive, inthe treatment of peritoneal infections.

  • 7/28/2019 Peritonitis Dr. Efman

    30/41

    Medical support includes

    (1) systemic antibiotic therapy;

    (2) intensive care with hemodynamic, pulmonary, renalreplacement support;

    (3) nutrition and metabolic support;

    (4) inflammatory response modulation therapy.

    Nonoperative interventional therapies include: (1) percutaneous drainage of abscesses and

    (2) percutaneous and endoscopic stent placements.

  • 7/28/2019 Peritonitis Dr. Efman

    31/41

    Medical Therapy & Preoperative

    preparationAntibiotic therapy

    In SBP, initiate empiric therapy with a third-generationcephalosporin and then tailor therapy according to the cultureresults. Avoid amino glycosides because patients with chronic liverdisease are at an increased risk for nephrotoxicity.

    In secondary and tertiary peritonitis, begin empiric therapy as soonas the diagnosis of peritoneal infection is suspected. The initialtherapy for SP must be mainly active against gram-negativeorganisms (e.g., E coli, Enterobacteriaceae species) and anaerobes(e.g., B fragilis). A combination of ampicillin, aminoglycoside, andmetronidazole can cover the whole spectrum.

    Nasogastric tube is inserted Foley catheter is inserted

    Analgesic for pain

  • 7/28/2019 Peritonitis Dr. Efman

    32/41

    Nonoperative drainage

    Aim: effective source control with avoidance of surgical therapy.

    to delay surgery until the acute process and sepsis are resolved and adefinitive procedure can be performed under elective circumstances.

    When considering primary percutaneous management of intraabdominalabscesses, clearly establishing the etiology, location, and morphology of

    the abscess prior to drainage is important; evaluate for the presence ofongoing enteric leak or fistula formation. With proper indication, moststudies have reported success rates of greater than 80% (range 33-100%)for drainage oflocalized nonloculated abscesses;

    Common reasons for failure: enteric fistula (e.g., anastomotic dehiscence),

    pancreatic involvement, infected clot, and

    multiple or multiloculated abscesses.

  • 7/28/2019 Peritonitis Dr. Efman

    33/41

    Surgical Therapy

    Surgery remains an important therapeutic modality for all cases ofperitoneal infection.

    Any operation should address the first 2 principles of the treatmentof intra-peritoneal infections: early and definitive source controland elimination of bacteria and toxins from the abdominal cavity.

    The issue of timing and adequacy of surgical source control isparamount because an improper, untimely, or incorrect operationmay have an overwhelmingly negative effect on outcome(compared to medical therapy).

    The operative approach is directed by the underlying diseaseprocess and the type and severity of the intra-abdominal infection.

    However, in severe abdominal sepsis, a delay of operativemanagement may lead to a significantly higher need forreoperations and overall worse outcomes; early exploration (ie,prior to completion of diagnostic studies) may be indicated.

  • 7/28/2019 Peritonitis Dr. Efman

    34/41

    Operation General anesthesia

    A vertical midline incision is the incision of choice in most patients with

    generalized peritonitis because it allows access to the entire peritoneal

    cavity. In patients with localized peritonitis (eg, acute appendicitis,

    cholecystitis), an incision directly over the site of pathology (eg, right lower

    quadrant, right subcostal) is usually adequate. In patients with an unclear

    etiology of the peritonitis, initial diagnostic laparoscopy may be useful.

    Pus is sampled

    Primary lesion is dealt with (The intra-abdominal anatomy may be

    significantly distorted because of inflammatory masses and adhesions.

    Normal tissue planes and boundaries may be obliterated. The inflamed

    organs are often very friable, and the surgeon must exercise great caution

    when exploring the patient with peritoneal infection).

    Peritoneal toilet by copious irrigation

    Drainage of the peritoneal cavity and subcutaneous space.

  • 7/28/2019 Peritonitis Dr. Efman

    35/41

    Open-abdomen technique and scheduled reoperation

    Second-look operations may be used in a damage control fashion.

    In these cases, the patient at initial operation is severely ill and

    unstable from septic shock or coagulopathy (eg, mediator liberation,

    disseminated intravascular coagulation).

    The goal of the initial operation is to provide preliminary drainage

    and to remove obviously necrotic tissue. Then, the patient is

    resuscitated and stabilized in an ICU setting for 24-36 hours and

    returned to the operating room for a more definitive drainage and

    source control.

    In conditions related to bowel ischemia, the initial operation aims to

    remove all frankly devitalized bowel. The second-look operation

    serves to reevaluate for further demarcation and decision-making

    regarding reanastomosis or diversion.

  • 7/28/2019 Peritonitis Dr. Efman

    36/41

    Laparoscopy

    Laparoscopy is gaining wider acceptance in thediagnosis and treatment of abdominal infections.

    Initial laparoscopic examination of the abdomen canassist in determination of the etiology of peritonitis

    (eg, right lower quadrant pathology in female patients).

    Successful laparoscopic repair of perforated gastric andduodenal ulcers has also been reported.

    The treatment of perihepatic infections vialaparoscopic approach has been well established inacute cholecystitis

  • 7/28/2019 Peritonitis Dr. Efman

    37/41

    Open Abdomen Technique

    One of the critical decisions in the surgical treatment of patients with severeperitonitis is regarding whether to use a closed-abdomen or open-abdomentechnique: The goal of the closed-abdomen technique is to provide definitive surgical treatment at the

    initial operation; perform primary fascial closure and perform repeat laparotomy only whenclinically indicated.

    The goal of the open-abdomen technique is to provide easy direct access to the affected area.

    Source control is achieved through repeated reoperations or open packing of the abdomen. This technique may be well suited for initial damage control in extensive

    peritonitis.

    Also consider patients who are at high risk for development of abdominalcompartment syndrome (eg, intestinal distension, extensive abdominal wall andintra-abdominal organ edema) for this technique because attempts to performprimary fascial closure under significant tension in these circumstances are

    associated with an increased incidence of MOF (eg, renal, respiratory), necrotizingabdominal wall infections, and mortality.

  • 7/28/2019 Peritonitis Dr. Efman

    38/41

    Nutrition

    In general, patients with peritonitis develop somedegree of gut dysfunction (e.g., ileus) after exploration.

    Consider establishing some form of nutritional supportearly in the course of treatment because most patients

    have an insufficient enteral intake for a variableamount of time preoperatively.

    The existing data support that enteral nutrition issuperior to parenteral hyperalimentation.

    If enteral feeding is contraindicated or not tolerated,parenteral nutrition should be instituted.

  • 7/28/2019 Peritonitis Dr. Efman

    39/41

    Complications

    Surgical site infection/dehiscence The incidence of surgical site infection increases

    with the degree of contamination

    Therefore, surgical site infection occurs at muchhigher rates after operations for peritonitis andperitoneal abscess (i.e., 5-15% compared to

  • 7/28/2019 Peritonitis Dr. Efman

    40/41

  • 7/28/2019 Peritonitis Dr. Efman

    41/41

    Complications

    Impaired wound healing

    The same factors that impair clearance of theabdominal infection contribute to increased problemsrelated to wound healing (eg, malnutrition, severe

    sepsis, multiple organ system dysfunction, advancedage, immunosuppression) and should be addressedaggressively.

    Patients with severe abdominal infections demonstrate

    higher incidences of fascial dehiscence and incisionalhernia development, requiring later reoperation.